Pipeline· July 28, 2026 · 25 min read
Topic
M&A
Mergers and acquisitions, licensing deals, partnership terms, and alliance structures that reshape therapeutic-area competition and pipeline strategy.
Deals· July 24, 2026 · 16 min read
Sun Pharma's $11.75B Organon Buy: India's Largest Drugmaker Bets on Women's Health
By Ran Chen#M&A#Biosimilars
Deals· July 23, 2026 · 17 min read
Novartis Ends Last Big-Pharma ADC Holdout: The $1.5B Myricx Deal
Deals· July 22, 2026 · 18 min read
Vertex's $10B Crinetics Acquisition: Paltusotine and Rare Endocrine Bet
By Ran Chen#M&A#Orphan Drug#Rare Disease
Deals· July 21, 2026 · 17 min read
AbbVie's $10.9B Apogee Acquisition: The Zumilokibart Immunology Bet
By Ran Chen#M&A#Immunology#Payer Coverage
Deals· July 20, 2026 · 17 min read
2026 biopharma M&A by the numbers: 33 deals and $134 billion already eclipse all of 2025
By Ran Chen#M&A#Oncology#Immunology
Deals· June 12, 2026 · 7 min read
GSK pays $10.6B for Nuvalent: zidesamtinib PDUFA Sept 2026, two NSCLC franchises
By Ran Chen#M&A#Oncology#FDA Approval